Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)
Francis B Panosyan, Matilde Laura, Alexander M Rossor, Chiara Pisciotta, Giuseppe Piscosquito, Joshua Burns, Jun Li, Sabrina W Yum, Richard A Lewis, John Day, Rita Horvath, David N Herrmann, Michael E Shy, Davide Pareyson, Mary M Reilly, Steven S Scherer, Inherited Neuropathies Consortium—Rare Diseases Clinical Research Network (INC-RDCRN), Richard Lewis, John Day, Gyula Acsadi, Mario Saporta, Stephan Züchner, Richard Finkel, Michael Shy, Shawna Feely, Thomas Lloyd, Vera Fridman, Sindhu Ramchandren, David Walk, David Herrmann, Erig Logigian, Michael Stanton, Katy Eichinger, Debra Guntrum, Cindy Gibson, Steven Scherer, Sabrina Yum, Jun Li, Joshua Burns, Davide Pareyson, Isabella Moroni, Chiara Pisciotta, Mary Reilly, Matilde Laurá, Francesco Muntoni, Francis B Panosyan, Matilde Laura, Alexander M Rossor, Chiara Pisciotta, Giuseppe Piscosquito, Joshua Burns, Jun Li, Sabrina W Yum, Richard A Lewis, John Day, Rita Horvath, David N Herrmann, Michael E Shy, Davide Pareyson, Mary M Reilly, Steven S Scherer, Inherited Neuropathies Consortium—Rare Diseases Clinical Research Network (INC-RDCRN), Richard Lewis, John Day, Gyula Acsadi, Mario Saporta, Stephan Züchner, Richard Finkel, Michael Shy, Shawna Feely, Thomas Lloyd, Vera Fridman, Sindhu Ramchandren, David Walk, David Herrmann, Erig Logigian, Michael Stanton, Katy Eichinger, Debra Guntrum, Cindy Gibson, Steven Scherer, Sabrina Yum, Jun Li, Joshua Burns, Davide Pareyson, Isabella Moroni, Chiara Pisciotta, Mary Reilly, Matilde Laurá, Francesco Muntoni
Abstract
Objective: To extend the phenotypic description of Charcot-Marie-Tooth disease (CMTX1) and to draw new genotype-phenotype relationships.
Methods: Mutations in GJB1 cause the main X-linked form of CMTX (CMTX1). We report cross-sectional data from 160 patients (from 120 different families, with 89 different mutations) seen at the Inherited Neuropathies Consortium centers.
Results: We evaluated 87 males who had a mean age of 41 years (range 10-78 years) and 73 females who had a mean age of 46 years (range 15-84 years). Sensory-motor polyneuropathy affects both sexes, more severely in males than in females, and there was a strong correlation between age and disease burden in males but not in females. Compared with females, males had more severe reduction in motor and sensory neurophysiology parameters. In contrast to females, the radial nerve sensory response in older males tended to be more severely affected compared with younger males. Median and ulnar nerve motor amplitudes were also more severely affected in older males, whereas ulnar nerve motor potentials tended to be more affected in older females. Conversely, there were no statistical differences between the sexes in other features of the disease, such as problems with balance and hand dexterity.
Conclusions: In the absence of a phenotypic correlation with specific GJB1 mutations, sex-specific distinctions and clinically relevant attributes need to be incorporated into the measurements for clinical trials in people with CMTX1.
Clinicaltrialsgov identifier: NCT01193075.
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Figures
References
- Fridman V, Bundy B, Reilly MM, et al. . CMT subtypes and disease burden in patients enrolled in the INC natural history study (6601) from 2009 to 2013. J Neurol Neurosurg Psychiatry 2015;86:873–878.
- Bergoffen J, Scherer SS, Wang S, et al. . Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993;262:2039–2042.
- Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996;238:1–27.
- Balice-Gordon RJ, Bone LJ, Scherer SS. Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 1998;142:1095–1104.
- Tomaselli PJ, Rossor AM, Horga A, et al. . Mutations in non-coding regions of GJB1 are a major cause of X-linked CMT. Neurology 2017;88:1445–1453.
- Kleopa KA, Abrams CK, Scherer SS. How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease? Brain Res 2012;1487:198–205.
- Shy ME, Siskind C, Swan ER, et al. . CMT1X phenotypes represent loss of GJB1 gene function. Neurology 2007;68:849–855.
- Rozear MP, Pericakvance MA, Fischbeck K, et al. . Hereditary motor and sensory neuropathy, X-linked—a half century follow-up. Neurology 1987;37:1460–1465.
- Hahn AF. Hereditary motor and sensory neuropathy—HMSN type-II (neuronal type) and X-linked HMSN. Brain Pathol 1993;3:147–155.
- Nicholson G, Nash J. Intermediate nerve-conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993;43:2558–2564.
- Hahn AF, Bolton CF, White CM, et al. . Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease. Ann N Y Acad Sci 1999;883:366–382.
- Dubourg O, Tardieu S, Birouk N, et al. . Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain 2001;124:1958–1967.
- Siskind CE, Murphy SM, Ovens R, Polke J, Reilly MM, Shy ME. Phenotype expression in women with CMT1X. J Peripher Nerv Syst 2011;16:102–107.
- Scherer SS, Xu YT, Nelles E, Fischbeck K, Willecke K, Bone LJ. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 1998;24:8–20.
- Shy ME, Blake J, Krajewski K, et al. . Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005;64:1209–1214.
- Murphy SM, Herrmann DN, McDermott MP, et al. . Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2011;16:191–198.
- Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 2013;111:52–58.
- Birouk N, Le Guern E, Maisonobe T, et al. . X-linked Charcot-Marie-Tooth disease with connexin 32 mutations—clinical and electrophysiological study. Neurology 1998;50:1074–1082.
- Arthur-Farraj PJ, Murphy SM, Laura M, et al. . Hand weakness in Charcot-Marie-Tooth disease 1X. Neuromuscul Disord 2012;22:622–626.
- Ekins S, Litterman NK, Arnold RJG, et al. . A brief review of recent Charcot-Marie-Tooth research and priorities. F1000Res 2015;4:53.
- Klein D, Patzko A, Schreiber D, et al. . Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Brain 2015;138:3193–3205.
- Kagiava A, Sargiannidou I, Theophilidis G, et al. . Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy. Proc Natl Acad Sci USA 2016;113:E2421–E2429.
Source: PubMed